Surgeons Present Their Experiences with Aortic Arch Repair at AATS 2009
Ann Arbor, MI — May 13, 2009 — Terumo Cardiovascular Systems and Vascutek Terumo hosted a series of presentations by leading surgeons at the Terumo exhibit during the 89th Annual Meeting of The American Association of Thoracic Surgeons, May 10-12, in Boston, Massachusetts. The surgeons presented their experiences with aortic arch repair. Presentations included:
G. Chad Hughes, MD, Duke University Medical Center
Arch Repair, the Duke Way
Joseph E. Bavaria, MD, Hospital of the University of Pennsylvania
A Conceptual Framework for Arch Repair
David Spielvogel, MD, Westchester Medical Center
Arch Repair Techniques Using a Trifurcated Graft
Edward Chen, MD, Emory University Hospital
Updates in Aortic Arch Repair from Emory University Hospital
More information can be found at www.terumo-cvs.com/AATS_speakers.shtml.
Terumo Cardiovascular Systems Corporation is a global manufacturer and marketer of medical devices for cardiac and vascular surgery. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; and Ashland, Massachusetts. It is one of several subsidiaries of Terumo Corporation of Japan focused exclusively on the cardiac and vascular markets, including Terumo Heart, Inc., developer of a left ventricular assist device, and Vascutek Terumo, world leading manufacturer of vascular grafts. For more information, visit www.terumo-cvs.com.
Based in Renfrewshire, Scotland, Vascutek Terumo uses innovative vascular technologies to develop products that address the needs of cardiac and vascular surgeons throughout the world. Founded in 1982, Vascutek was one of the first medical device manufacturers to affix the CE mark to its products. The company was acquired by Terumo Corporation in 2002. Vascutek is guided by an ethos of technical excellence, stringent quality control and total customer service. For more information, visit www.vascutek.com
Terumo Corporation is a premier global medical device company with annual sales of nearly three billion dollars for the year ending March 31, 2008. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products.